https://www.siapecmdp.it/project/sponsor-2/2020-10-22T17:45:44+02:00https://www.siapecmdp.it/project/bayer/2020-10-26T22:35:35+02:00https://www.siapecmdp.it/project/thermofisher/2020-10-26T22:33:03+02:00https://www.siapecmdp.it/project/articolo-thermofisher/2020-08-03T10:43:09+02:00https://www.siapecmdp.it/project/roche/2020-12-10T17:54:15+02:00https://www.siapecmdp.it/project/tesi/2020-10-26T22:37:48+02:00https://www.siapecmdp.it/project/agilent/2020-10-26T22:34:22+02:00https://www.siapecmdp.it/project/epredia/2020-10-26T22:29:55+02:00https://www.siapecmdp.it/project/bio-optica/2020-11-27T12:00:47+02:00https://www.siapecmdp.it/project/tissue-micro-arrays/2020-09-18T13:07:02+02:00https://www.siapecmdp.it/project/leica-biosystems/2020-10-26T22:36:39+02:00https://www.siapecmdp.it/project/one-roche-oncology-infinite-sinergie-la-somma-di-numeri-uno/2020-10-20T18:40:12+02:00https://www.siapecmdp.it/project/menarini/2020-10-26T22:31:39+02:00https://www.siapecmdp.it/project/roche-digital-pathology/2020-11-02T16:26:32+02:00https://www.siapecmdp.it/project/roche-a-supporto-del-sistema-sanitario-per-le-donne-con-carcinoma-mammario-triplo-negativo-tnbc/2020-11-02T16:13:37+02:00https://www.siapecmdp.it/project/digital-pathology-e-scanner-di-vetrini-digitali/2020-11-02T18:52:02+02:00https://www.siapecmdp.it/project/_menarini/2020-12-01T18:46:23+02:00https://www.siapecmdp.it/project/navify-mutation-profiler/2020-12-01T18:43:58+02:00https://www.siapecmdp.it/project/roche-cytomatrix-la-nuova-frontiera-della-citologia/2020-12-09T21:17:27+02:00https://www.siapecmdp.it/project/roche-raccomandazioni-esmo-sullimpiego-di-ngs-per-pazienti-con-cancro-metastatico-la-strada-verso-la-medicina-personalizzata/2020-12-09T21:12:37+02:00https://www.siapecmdp.it/project/roche_navify-tumor-board-e-la-virtualizzazione-in-oncologia/2020-12-10T17:37:57+02:00https://www.siapecmdp.it/project/cintec-plus-cytology-approvato-fda/2020-12-15T15:04:20+02:00https://www.siapecmdp.it/project/ruolo-del-market-access-nel-contesto-diagnostico-italiano/2020-12-16T16:39:54+02:00https://www.siapecmdp.it/project/buone-feste/2020-12-23T14:23:16+02:00https://www.siapecmdp.it/project/exact-sciences/2021-06-03T11:34:58+02:00https://www.siapecmdp.it/project/le-linee-guida-aggiornate-del-national-comprehensive-cancer-network-classificano-come-preferito-il-test-oncotype-dx/2021-05-28T09:52:23+02:00https://www.siapecmdp.it/project/comunicazione-di-exact-sciences-sullistituzione-del-fondo-per-il-rimborso-nazionale-dei-test-genomici/2021-05-28T09:52:47+02:00https://www.siapecmdp.it/project/i-risultati-dello-studio-rxponder-dimostrano-che-un-test-genomico-puo-evitare-lutilizzo-della-chemioterapia-nella-maggior-parte-delle-donne-con-tumore-del-seno-in-fase-iniziale-e-linfonodi-po/2021-05-28T09:54:33+02:00